Browse categories and answer follow-up questions to refine your symptom profile.
Approach to the Critical Patient
Immediate priorities
High risk obstetric hemorrhage approach
Resuscitation bay triggers
Systolic blood pressure <90 mmHg
Heart rate >120 beats/min
Altered mental status
Ongoing heavy vaginal bleeding
Airway and breathing
If respiratory distress or shock, airway support and oxygenation
If intubation, left uterine displacement
Circulation
Two large bore IV lines
Rapid transfuser readiness
If shock, activate massive transfusion protocol
Monitoring
Continuous ECG
Continuous pulse oximetry
Noninvasive blood pressure every 3 to 5 minutes
If unstable, arterial line for titration and frequent sampling
Hemorrhage and fetal safety
Maternal first framework
Maternal stabilization as priority for fetal survival
Left uterine displacement to reduce aortocaval compression
Normothermia and active warming
Calcium monitoring during transfusion
Fetal assessment integration
Continuous external fetal monitoring if viable gestational age and resources available
Category III fetal heart tracing as urgent obstetric escalation trigger
Bedside ultrasound for fetal cardiac activity if uncertainty
Consults and time critical decisions
Team activation
Obstetrics immediate involvement
Anesthesia early involvement for possible operative delivery
Neonatology if preterm viable fetus
Blood bank notification for anticipated high product use
Delivery decision points
If maternal instability, immediate delivery pathway based on obstetric assessment
If fetal distress with viable fetus, expedited delivery pathway
If fetal demise, maternal stabilization and hemorrhage control focus
Transfer considerations
If no operative obstetric capability, immediate transfer planning with ongoing resuscitation
If unstable, transfer only if safer than local temporizing delivery options
History
Core presentation
Symptom pattern
Vaginal bleeding
Concealed abruption possibility with minimal external bleeding
Sudden onset bleeding
Abdominal pain
Constant pain
Back pain
Uterine activity
Frequent contractions
Hypertonic uterus sensation
Decreased fetal movements
Recent change from baseline
Time since last perceived movement
Timeline
Gestational age estimate
Symptom onset time
Bleeding quantity progression
Pain progression
Risk factors
Maternal and pregnancy risks
Hypertensive disorders of pregnancy
Preeclampsia or gestational hypertension
Chronic hypertension
Trauma
Motor vehicle collision
Fall
Intimate partner violence
Prior abruption
Previous pregnancy history
Substance exposure
Cocaine or stimulant use
Tobacco use
Uterine factors
Uterine overdistension
Multiple gestation
Polyhydramnios
Membrane and cord factors
Premature rupture of membranes
Short umbilical cord concern
Medication and bleeding risks
Anticoagulant use
Known bleeding disorder
Obstetric context and comorbidities
Pregnancy history
Gravidity and parity
Prior cesarean delivery
Prior placenta previa history
Current pregnancy complications
Fetal growth restriction
Known placental abnormalities
Baseline health
Cardiovascular disease
Renal disease
Diabetes mellitus
PITFALLS
Common misses
Reassurance from low visible bleeding
Reassurance from a normal ultrasound
Anchoring on placenta previa without considering abruption
Delayed blood product activation in apparent stable patients
Physical Exam
Maternal hemodynamics and perfusion
Vital signs and shock markers
Hypotension
Narrow pulse pressure
Orthostatic changes
Tachycardia
Tachypnea
Fever alternative diagnosis consideration
Shock index elevation
Perfusion exam
Capillary refill delay
Cool clammy extremities
Altered mental status
Oliguria or anuria
Abdominal and uterine findings
Uterine tone and tenderness
Firm board like uterus
Uterine tenderness
Persistent contractions
Abdominal exam
Guarding or peritonism
Fundal height discrepancy
Vaginal bleeding assessment
External bleeding quantity
Clots
Cervical dilation status if assessed by obstetrics
Fetal assessment
Bedside fetal status
Fetal heart rate presence
Fetal heart rate pattern if monitoring in place
Contraction pattern
Frequent contractions
Uterine tachysystole
PITFALLS
Exam limitations
Normal appearing cervix does not exclude abruption
Soft uterus early does not exclude evolving abruption
Pain out of proportion as a severe sign even with scant bleeding
Differential Diagnosis
Obstetric life threats
Bleeding in pregnancy differential
Placenta previa ICD-10 O44
Vasa previa
Uterine rupture ICD-10 O71.1
Cervical insufficiency with bleeding
Preterm labor with bloody show
Hypertensive and placental disorders
Severe preeclampsia with hepatic involvement
HELLP syndrome ICD-10 O14.2
Infection and inflammation
Chorioamnionitis
Non obstetric mimics and contributors
Abdominal pain mimics
Appendicitis
Ovarian torsion
Nephrolithiasis
Hemorrhage sources
Cervical or vaginal laceration
Uterine atony postpartum context
Trauma related
Solid organ injury with hemoperitoneum
Laboratory Tests
Hemorrhage and anemia
Hemoglobin and platelets overview
Complete blood count for bleeding concern
Hemoglobin trend for occult loss
Platelet count for consumption and transfusion planning
Type and screen
Antibody screen status
Crossmatch volume planning
Metabolic and perfusion markers
Venous blood gas or arterial blood gas if shock
pH and bicarbonate for severity
PaCO2 and PaO2 in mmHg if arterial sample
Lactate in mmol/l
Trend for resuscitation response
Persistent elevation as ongoing hypoperfusion marker
Coagulopathy and DIC risk
Coagulation panel
INR and PT for consumption
Rising INR as DIC marker
Target normalization with plasma guided therapy
aPTT for consumption
Prolongation as DIC marker
Fibrinogen
Low fibrinogen as early severe abruption marker
Replacement targets in active bleeding per obstetric massive hemorrhage protocols
D dimer context
Pregnancy baseline elevation limitation
Trend and extreme elevation supportive of DIC
Chemistry for organ injury
Creatinine and electrolytes
Acute kidney injury in shock
Potassium abnormalities during massive transfusion
AST and ALT if hypertensive disease concern
HELLP overlap evaluation
Fetomaternal hemorrhage and Rh management
Rh and fetomaternal hemorrhage evaluation
Maternal ABO and Rh status
Rh negative as Rh immune globulin trigger
Kleihauer Betke or flow cytometry
Fetomaternal hemorrhage quantification for Rh immune globulin dosing
Diagnostic Tests
Scoring Systems
Risk stratification and severity frameworks
Shock index
Heart rate divided by systolic blood pressure for early shock detection
Rising value as escalation trigger
ISTH DIC score adaptation
Platelets, PT prolongation, fibrin related markers, fibrinogen
Higher score supportive of overt DIC in bleeding patient
MRI
Limited acute role
Stable patient evaluation only
Placental pathology characterization when diagnosis uncertain
Not a time critical test in hemorrhage
Practical constraints
Availability and time delays
Monitoring limitations in unstable patient
CT
Generally avoided for primary diagnosis
Radiation considerations
Use only when alternative diagnosis suspected and benefits outweigh risk
Trauma evaluation pathways when indicated
Alternative diagnosis support
Intraabdominal injury after trauma
Non obstetric abdominal catastrophe in pregnancy
Ultrasound (or US)
Bedside imaging use
Placental evaluation
Retroplacental hematoma detection
Placental thickening
Subchorionic collection
Test limitations
Normal ultrasound does not exclude abruption
Sensitivity limited especially in acute or concealed abruption
Fetal assessment
Fetal cardiac activity confirmation
Amniotic fluid assessment
Fetal presentation for delivery planning
Fetal monitoring
Cardiotocography
Continuous monitoring when viable gestation and resources
Recurrent late decelerations as uteroplacental insufficiency marker
Bradycardia as severe compromise marker
Contraction monitoring
Tachysystole association with abruption
Hypertonus association with abruption
Disposition
Level of care
Admission pathways
Labor and delivery admission
Suspected or confirmed abruption
Any nontrivial bleeding with pain or uterine hypertonus
ICU or high acuity monitoring
Hemodynamic instability
Ongoing transfusion requirement
DIC or evolving coagulopathy
Operative readiness
Immediate access to cesarean delivery capability when indicated
Anesthesia presence for unstable patient
Transfer and discharge
Transfer criteria
No obstetric operative capability locally
Transfer to tertiary obstetric center
Ongoing resuscitation during transfer
Extreme prematurity with neonatal care needs
Discharge criteria
Generally uncommon for suspected abruption
Minimal bleeding without pain and reassuring fetal assessment as obstetric decision only
Clear return precautions and rapid follow up plan
Treatment
Resuscitation and hemorrhage control
Immediate stabilization bundle
Positioning
Left uterine displacement
Supine avoidance if symptomatic hypotension
Fluids and products
Balanced crystalloid as bridge only
Early blood products for ongoing hemorrhage
Massive transfusion protocol
If ongoing hemorrhage with shock, activate immediately
Targeted hemostatic resuscitation with lab guided adjustments
Temperature and calcium
Active warming
IV calcium replacement during high volume transfusion
Blood products and hemostasis
Packed red blood cells
Transfusion triggers individualized to shock and ongoing bleeding
Goal perfusion and oxygen delivery rather than single hemoglobin number
Plasma and platelets
If coagulopathy with bleeding, plasma support
If thrombocytopenia with bleeding or operative need, platelets support
Fibrinogen replacement
Cryoprecipitate or fibrinogen concentrate based on local protocol
If fibrinogen low with bleeding, replace early
Repeat fibrinogen monitoring after replacement
Tranexamic acid
If massive obstetric hemorrhage, consider per institutional obstetric hemorrhage protocol
Greatest evidence base in postpartum hemorrhage
Use in antepartum hemorrhage as specialist guided decision
Obstetric management and delivery planning
Delivery strategy based on maternal and fetal status
If maternal instability, expedited delivery decision with obstetrics
Cesarean delivery if viable fetus and maternal condition allows
Vaginal delivery pathway if fetal demise and maternal stabilization achievable
If fetal distress with viable fetus, expedited delivery
If stable and mild suspected abruption, expectant management in hospital with continuous monitoring
Avoidance of tocolysis in significant abruption
Ongoing bleeding as contraindication to tocolysis
Specialist decision only in selected mild cases
Medications and adjuncts
Analgesia and antiemetics
Opioid analgesia titrated to effect with maternal monitoring
Antiemetic therapy if vomiting contributes to distress
Corticosteroids for fetal lung maturity
If preterm viable gestation and expectant management planned, antenatal corticosteroids per obstetrics
Magnesium sulfate
If imminent preterm delivery for neuroprotection per obstetrics
Hypertension management
If severe range blood pressure, antihypertensive therapy per obstetrics protocol
IV labetalol protocol
Initiate 20 mg IV
If inadequate response, 40 mg IV after 10 minutes
If inadequate response, 80 mg IV every 10 minutes
Maximum cumulative 220 mg
IV hydralazine protocol
Initiate 5 to 10 mg IV
Repeat 5 to 10 mg IV every 20 to 40 minutes
Oral nifedipine immediate release protocol
Initiate 10 mg orally
Repeat 20 mg orally after 20 minutes if needed
Antibiotics
Not routine for abruption alone
If chorioamnionitis suspected, broad spectrum antibiotics per obstetrics protocol
Rh immune globulin
Rh negative patient pathway
Rh immune globulin administration
Dose per gestational age and fetomaternal hemorrhage testing
Additional dosing guided by Kleihauer Betke or flow cytometry
Special Populations
Pregnancy
Pregnancy specific physiology and safety
Increased plasma volume with delayed hypotension
Tachycardia as early shock sign
Concealed hemorrhage risk
Aortocaval compression effects
Left uterine displacement impact on perfusion
Medication safety
Avoid teratogenic agents
Prefer obstetric approved hemorrhage protocols
Coding and terminology
Abruptio placentae ICD-10 O45.0 to O45.9
SNOMED CT concept abruptio placentae
Geriatric
Older pregnant patient considerations
Higher baseline cardiovascular risk
Lower tolerance for hypovolemia
Earlier ICU threshold
Medication sensitivity
Lower opioid dosing thresholds
Careful antihypertensive titration
Pediatrics
Adolescent pregnancy considerations
Confidentiality and safeguarding needs
Screening for interpersonal violence
Social work involvement when appropriate
Lower baseline blood volume
Faster decompensation risk
Early blood product activation threshold
Background
Epidemiology
Disease frequency and outcomes
Placental abruption as a cause of antepartum hemorrhage
Most common in third trimester
Can occur at any gestational age
Maternal outcomes
Hemorrhagic shock risk
DIC risk with severe abruption
Fetal outcomes
Preterm birth risk
Fetal growth restriction association
Stillbirth risk in severe cases
Pathophysiology
Mechanism
Premature separation of placenta from uterine wall
Retroplacental hematoma formation
Disruption of uteroplacental exchange
Bleeding patterns
Revealed bleeding with vaginal bleeding
Concealed bleeding with intramyometrial tracking
Coagulopathy pathway
Tissue factor release and consumptive coagulopathy
Hypofibrinogenemia as early marker in severe cases
Therapeutic Considerations
Management principles
Maternal stabilization reduces fetal risk
Oxygen delivery and uterine perfusion dependence
Delivery as definitive treatment for severe cases
Maternal instability or fetal distress as common triggers
Hemostatic resuscitation
Early balanced blood product support
Fibrinogen focused replacement in obstetric hemorrhage
Evidence framing
Many recommendations based on expert consensus and institutional obstetric hemorrhage pathways
Class I recommendation for immediate obstetric consultation in suspected abruption with instability
ACEP Level C recommendation for early massive transfusion activation in life threatening hemorrhage
Patient Discharge Instructions
copy discharge instructions
Discharge counseling bundle
Return to emergency care immediately for any of the following
Heavy vaginal bleeding
New or worsening abdominal pain
Regular painful contractions
Decreased fetal movements
Dizziness, fainting, chest pain, shortness of breath
Severe headache, vision changes, right upper quadrant pain
Activity guidance
Pelvic rest until obstetric follow up
Avoid strenuous activity until cleared
Follow up plan
Same day obstetric assessment if any recurrence of symptoms
Scheduled obstetric follow up within 24 to 48 hours if discharged by obstetrics
Medication guidance
Avoid NSAIDs unless explicitly advised by obstetrics
Use prescribed analgesics only as directed
References
Clinical guidelines and key sources
Core guidance sources
ACOG practice bulletins and committee opinions on antepartum hemorrhage and placental abruption
RCOG guidelines on antepartum hemorrhage
Society for Maternal Fetal Medicine consult series on late pregnancy bleeding and placental complications
Obstetric massive transfusion and hemorrhage protocols with fibrinogen focused resuscitation
Evidence based summaries
Major obstetric texts and review articles on diagnosis and ultrasound limitations
DIC scoring framework publications including ISTH DIC score
Trauma in pregnancy guidelines addressing placental abruption risk after blunt trauma
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.